Assembly Biosciences Picks Papkoff for Chief Scientific Officer

Assembly Biosciences (NASDAQ: [[ticker:ASMB]]) has appointed Jackie Papkoff senior vice president and chief scientific officer, microbiome. Papkoff most recently was a senior vice president for Cambridge, MA-based Evelo Biosciences. Carmel, IN-based Assembly is developing treatments for disorders associated with the human microbiome. Last year, Assembly began a collaboration agreement with Allergan (NYSE: [[ticker:AGN]]) to develop microbiome treatments for ulcerative colitis, Crohn’s disease, and other gastrointestinal disorders.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.